Wed, Sep 17, 2014, 9:03 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

plagioclase2002 5 posts  |  Last Activity: Sep 11, 2014 12:08 PM Member since: May 13, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • plagioclase2002 by plagioclase2002 Sep 11, 2014 12:08 PM Flag

    Subject to the whims of a totalitarian government - both the company & the USA.

  • Reply to

    THE STOCK

    by plagioclase2002 Jul 8, 2014 10:00 PM
    plagioclase2002 plagioclase2002 Jul 14, 2014 1:46 PM Flag

    There is a reasonable chance they will have the first drug in the CSC area. This should attract attention to the company [they do have impressive professional contacts for a $200 million company]. Beyond that they have to determine what works when & where. I believe the upside is substantial if things work out. Prefer the company to Stemline on an operating basis & to OMED on a cap basis.

  • Reply to

    THE STOCK

    by plagioclase2002 Jul 8, 2014 10:00 PM
    plagioclase2002 plagioclase2002 Jul 10, 2014 10:25 AM Flag

    Yes - I like it on a long term basis. Will answer your question in more detail later. When allocating $ the small biotech's are essentially venture capital companies. Today I am focused on the general market - may be setting up for an opportunity. Forget the blah, blah on CNBC. They will look back at a higher stock market & the why will be obvious. The substantial amount of money to be continually invested. Sovereign funds, hedge funds, mutual funds, colleges, museums, family trusts, money seeking safe haven from every corner of the world, illegal money, etc, etc. With increasing interest rates fixed income will be less interesting.

  • plagioclase2002 by plagioclase2002 Jul 8, 2014 10:00 PM Flag

    Realize that this is a relatively thin stock - but the day to day price action is strange. It is obvious that a large holder[s] is selling. Individuals are not the only ones buying high & selling low. On R & D Day - numerous institutions are doing good work on CSC. An update would be helpful.

  • plagioclase2002 by plagioclase2002 May 14, 2014 8:50 AM Flag

    With the ipo in early 2012 @$10 & a secondary @$15 no holder has a profit. I wonder where the stock for sale is coming from. With the progress in two years & the stock at a discount it looks interesting. Evidently the directors don't agree.

SNTA
3.72+0.05(+1.36%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.